TXMD
Price:
$1.61
Market Cap:
$18.63M
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes b...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2007-05-09
Stock Exchange
NASDAQ
Ticker
TXMD
According to TherapeuticsMD, Inc.’s latest financial reports and current stock price. The company's current ROE is -1.69%. This represents a change of 286.76% compared to the average of -0.44% of the last 4 quarters.
The mean historical ROE of TherapeuticsMD, Inc. over the last ten years is -186.43%. The current -1.69% ROE has changed -99.09% with respect to the historical average. Over the past ten years (40 quarters), TXMD's ROE was at its highest in in the March 2021 quarter at 415.52%. The ROE was at its lowest in in the June 2019 quarter at -682.44%.
Average
-186.43%
Median
-47.15%
Minimum
-2130.47%
Maximum
318.69%
Discovering the peaks and valleys of TherapeuticsMD, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.47%
Maximum Annual ROE = 318.69%
Minimum Annual Increase = -111.01%
Minimum Annual ROE = -2130.47%
| Year | ROE | Change |
|---|---|---|
| 2024 | -7.97% | -77.29% |
| 2023 | -35.09% | -111.01% |
| 2022 | 318.69% | 45.11% |
| 2021 | 219.61% | 28.03% |
| 2020 | 171.53% | -108.05% |
| 2019 | -2130.47% | 1.47% |
| 2018 | -135.98% | 129.64% |
| 2017 | -59.21% | -16.00% |
| 2016 | -70.50% | -47.74% |
| 2015 | -134.91% | 20.41% |
The current ROE of TherapeuticsMD, Inc. (TXMD) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
91.88%
5-year avg
133.35%
10-year avg
-186.43%
TherapeuticsMD, Inc.’s ROE is greater than ProPhase Labs, Inc. (-409.18%), greater than Aytu BioPharma, Inc. (-47.40%), greater than Biofrontera Inc. (-1151.42%), greater than BiomX Inc. (-190.95%), greater than Gelteq Limited Ordinary Shares (-21.00%), greater than Ekso Bionics Holdings, Inc. (-90.71%), greater than Ernexa Therapeutics Inc. (-1949.32%), less than MapLight Therapeutics, Inc. (0%), greater than American Shared Hospital Services (-10.36%), greater than ProMIS Neurosciences, Inc. (-336.93%),
| Company | ROE | Market cap |
|---|---|---|
| -409.18% | $6.30M | |
| -47.40% | $15.96M | |
| -1151.42% | $9.65M | |
| -190.95% | $7.28M | |
| -21.00% | $10.10M | |
| -90.71% | $10.67M | |
| -1949.32% | $10.28M | |
| 0% | $14.48M | |
| -10.36% | $13.48M | |
| -336.93% | $9.98M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TherapeuticsMD, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TherapeuticsMD, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is TherapeuticsMD, Inc.'s ROE?
How is the ROE calculated for TherapeuticsMD, Inc. (TXMD)?
What is the highest ROE for TherapeuticsMD, Inc. (TXMD)?
What is the 3-year average ROE for TherapeuticsMD, Inc. (TXMD)?
What is the 5-year average ROE for TherapeuticsMD, Inc. (TXMD)?
How does the current ROE for TherapeuticsMD, Inc. (TXMD) compare to its historical average?